Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"
Public ClinicalTrials.gov record NCT00139776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of "Continuous Use" Of Celecoxib Vs. The "Usual Use" Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-inflammatory Medication for Control Of Their Pain
Study identification
- NCT ID
- NCT00139776
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 875 participants
Conditions and interventions
Conditions
Interventions
- Celecoxib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2005
- Primary completion
- Jan 31, 2008
- Completion
- Jan 31, 2008
- Last update posted
- Mar 28, 2021
2005 – 2008
United States locations
- U.S. sites
- 67
- U.S. states
- 25
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Peoria | Arizona | 85381 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85051 | — |
| Pfizer Investigational Site | Anaheim | California | 92801 | — |
| Pfizer Investigational Site | Huntington Beach | California | 92646 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Orange | California | 92868 | — |
| Pfizer Investigational Site | Paramount | California | 90723 | — |
| Pfizer Investigational Site | Stockton | California | 95204 | — |
| Pfizer Investigational Site | Tustin | California | 92780 | — |
| Pfizer Investigational Site | Walnut Creek | California | 94598 | — |
| Pfizer Investigational Site | Whittier | California | 90601 | — |
| Pfizer Investigational Site | Wheat Ridge | Colorado | 80033 | — |
| Pfizer Investigational Site | Danbury | Connecticut | 06810 | — |
| Pfizer Investigational Site | New Milford | Connecticut | 06776 | — |
| Pfizer Investigational Site | Waterbury | Connecticut | 06708 | — |
| Pfizer Investigational Site | Ocala | Florida | 34474 | — |
| Pfizer Investigational Site | Palm Harbor | Florida | 34684 | — |
| Pfizer Investigational Site | South Miami | Florida | 33143 | — |
| Pfizer Investigational Site | Tampa | Florida | 33614-7118 | — |
| Pfizer Investigational Site | Zephyrhills | Florida | 33542 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62704 | — |
| Pfizer Investigational Site | Dubuque | Iowa | 52001-7313 | — |
| Pfizer Investigational Site | Dubuque | Iowa | 52002 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40509 | — |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21218 | — |
| Pfizer Investigational Site | Clinton | Maryland | 20735 | — |
| Pfizer Investigational Site | Frederick | Maryland | 21702 | — |
| Pfizer Investigational Site | Greenbelt | Maryland | 20770 | — |
| Pfizer Investigational Site | Wheaton | Maryland | 20902 | — |
| Pfizer Investigational Site | Brockton | Massachusetts | 02301 | — |
| Pfizer Investigational Site | Jefferson City | Missouri | 65101 | — |
| Pfizer Investigational Site | Jefferson City | Missouri | 65109 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65807 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68516 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68134 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89106 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89144 | — |
| Pfizer Investigational Site | Great Neck | New York | 11021 | — |
| Pfizer Investigational Site | Manlius | New York | 13104 | — |
| Pfizer Investigational Site | Mineola | New York | 11501 | — |
| Pfizer Investigational Site | New York | New York | 10022-1009 | — |
| Pfizer Investigational Site | Rochester | New York | 14609 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103-4019 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44122 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210-1228 | — |
| Pfizer Investigational Site | Zanesville | Ohio | 43701 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97401 | — |
| Pfizer Investigational Site | Beaver | Pennsylvania | 15009 | — |
| Pfizer Investigational Site | Camp Hill | Pennsylvania | 17011 | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | 16635-0909 | — |
| Pfizer Investigational Site | Johnstown | Pennsylvania | 15904 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19152 | — |
| Pfizer Investigational Site | Johnson City | Tennessee | 37601 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | New Tazewell | Tennessee | 37825 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22205 | — |
| Pfizer Investigational Site | Renton | Washington | 98055 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
| Pfizer Investigational Site | Yakima | Washington | 98902-4876 | — |
| Pfizer Investigational Site | Yakima | Washington | 98902 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00139776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2021 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00139776 live on ClinicalTrials.gov.